Institutional investors hold a majority ownership of CELG through the 83.45% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
STANDARD LIFE INVESTMENTS LTD. Bought 147.4 Thousand shares of Celgene
STATE STREET GLOBAL ADVISORS LTD... Bought 117.8 Thousand shares of Celgene
ETHENEA INDEPENDENT INVESTORS SA Bought 100.0 Thousand shares of Celgene